Sunday, August 22, 2010
TIME magazine: Why cancer biomarkers haven’t lived up their hype - Wellness - TIME.com
In a recent paper in the Journal of the National Cancer Institute, clinical biochemist Eleftherios Diamandis uncovers some of bigger blunders in cancer-diagnosis techniques -- explaining how experimental data could be misinterpreted and how, as a result, once-touted breakthroughs turned out to be far less than met the eye. Diamandis spoke to TIME earlier this week about his findings, and about how fizzled hopes can affect medicine
Ovarian Cancer Awareness Speaker - Dr Ilana Cass (California) Sept 2nd 7:30 pm
Thursday, September 2nd at 7:30pm in the Social Hall
RSVP - see website or: (805) 497-7101
Come join us as Dr. Ilana Cass discusses the latest research and developments towards finding a cure. Most importantly, she will be educating us about the “silent symptoms” of Ovarian Cancer.
Medical News: Pay-for-Performance Prods Faster Imaging Reports - in Radiology, Diagnostic Radiology from MedPage Today
Note: pay for performance is a widely discussed issue
media: Cancer patient finds new life in crusade (how many attempts?)
Blogger note: how many attempts at a diagnosis??
"The first eight doctors Joan Wyllie saw for her persistent intestinal distress told her she was fine.
The ninth doctor, a psychologist, suggested the pain in her stomach was really all in her head and prescribed the antidepressant Elavil.
The 10th doctor diagnosed stage 3C and 4 ovarian cancer. Wyllie was given a 50 percent chance of surviving the 7½-hour surgery needed to remove hundreds of tumors, many of which had metastasized........."cont'd
EvidenceUpdates-Cochrane Collaboration review: Interventions for treating oral mucositis for patients with cancer receiving treatment
Note:"* Ratings pending – login to http://plus.mcmaster.ca/evidenceupdates in a few days if interested."
Abstract
Background
Treatment of cancer is increasingly effective but associated with short and long term side effects. Oral side effects, including
oral mucositis (mouth ulceration), remain a major source of illness despite the use of a variety of agents to treat them.
Objectives
To
assess the effectiveness of interventions for treating oral mucositis
or its associated pain in patients with cancer receiving
chemotherapy or radiotherapy or both.Plain language summary:
Interventions for treating oral mucositis for patients with cancer receiving treatment
Using a low level laser may reduce the severity of ulcers caused by cancer treatment.
Treatments for cancer can cause severe ulcers (sores) in the mouth. These can be painful and slow to heal. The review found weak and unreliable evidence that using a laser may relieve or cure the ulcers. Morphine can control the pain. Although using morphine automatically on a constant drip, or self controlled use, provide similar relief, people use less morphine when they are controlling it themselves.
NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline
"Pazopanib is currently approved by the FDA to treat patients with advanced renal cell carcinoma. The research grant to NCCN will evaluate the effectiveness of pazopanib in solid tumors including renal, sarcoma, thyroid, neuroendocrine, and ovarian cancers."
(abstract) From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer — Ann Oncol
Background: The objective of the study was to evaluate completion rates and toxic effects of an i.p. chemotherapy regimen in a cross-section of nonselected patients with ovarian cancer (OC).
Subscribe to:
Posts
(
Atom
)
Posts
